Metagenomi Therapeutics Inc. Company Profile
NASDAQ: MGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.99+0.0053 (+0.54%)
Market open · Delayed 15 min · as of Oct 8, 2:18 PM ET
Metagenomi Therapeutics at a glance
Metagenomi Therapeutics Inc. (NASDAQ: MGX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2024. At a market capitalization of $37.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001785279, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Metagenomi Therapeutics Inc.
- Ticker
- NASDAQ: MGX
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2024
- Market cap
- $37.20M
- SEC CIK
- 0001785279
Companies similar to Metagenomi Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELUTElutia Inc. Class A | 0.82 | -0.01% | $36.32M | vs MGX |
| CVMCel-Sci Corporation | 1.98 | -7.28% | $34.74M | vs MGX |
| GNTAGenenta Science S.p.A. ADR | 0.7199 | -4.65% | $34.71M | vs MGX |
| ALGSAligos Therapeutics Inc. | 5.35 | +0.56% | $33.41M | vs MGX |
| TVGNTevogen Inc. | 6.35 | -2.16% | $41.35M | vs MGX |
| TILInstil Bio Inc. | 6.51 | -5.04% | $44.12M | vs MGX |
| BSEMBioStem Technologies Inc. | 2.40 | +0.41% | $44.81M | vs MGX |
| QNCXQuince Therapeutics Inc. | 28.40 | +6.29% | $28.88M | vs MGX |